Efficacy and Safety of Lactoferrin in Heart Failure Patients

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 114 participants.

Also called NCT06427200

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 114 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06427200
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT06427200. Randomized; no masking; primary purpose treatment. Start 2024-07 (anticipated); primary completion 2027-07 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety of Lactoferrin in Heart Failure Patients
Intervention (Drug)
oral Iron
Intervention (Drug)
Lactoferrin
Intervention (Drug)
lactoferrin and oral iron
Lead sponsor
Cairo University (class: other)

Record details

Record id
cardio:ct-nct06427200
Content hash
d38e07719e1a6c716b6dff5434b7f0acc91ead1f64ec74fe0d2ab2c7dd314fcb